[1]
2022. Formulation and In-vivo Evaluation of Dasatinib-loaded Solid Lipid Nanoparticles. International Journal of Pharmaceutical Sciences and Drug Research. 14, 6 (Nov. 2022), 824–832. DOI:https://doi.org/10.25004/IJPSDR.2022.140621.